Our Networks

Six networks of 39 multidisciplinary teams
are involved in HTE program within this main aim:

Exploration and modeling of tumor heterogeneity and bi-directional interactions of tumor cells and their tumor microenvironment
which may act on tumor progression by cooperation of teams from different fields.

Pitcher

Principal investigator
PIERRE HAINAUT

Pitcher

Peritoneal carcinomatosis heterogeneity
> SEE MORE

MoGlimaging

Principal investigators
ELIZABETH COHEN-JONATHAN MOYAL
CHRISTINE TOULAS

MoGlimaging

Modeling of Glioblastoma treatment-induced resistance & heterogeneity by multimodal imaging

Chemotaxis in cancer

Principal investigator
GUIDO KROEMER

Chemotaxis in cancer

Explaining the heterogeneity of the immune infiltrates
> SEE MORE

EcoAML

Principal investigator
FRANÇOIS DELHOMMEAU

EcoAML

Dynamic crosstalks in the development of acute myeloid leukemias in their ecosystem
> SEE MORE

HetCoLi

Principal investigator
JESSICA ZUCMAN-ROSSI

HetCoLi

Deciphering the heterogeneous genome-microenvironment interplay in colon and hepatocellular carcinomas
> SEE MORE

This French program is organized by ITMO Cancer, in collaboration with ITMO BCDE (Cell Biology, Development and Evolution) and ITMO Technologies for Health of the National Alliance for Life Sciences and Health (AVIESAN) with the National Cancer Institute (INCA) and Inserm within the framework of the Cancer Plan. Operational management is entrusted to Inserm.
It was launch in order to develop a critical mass of resources and skills in order to conduct interdisciplinary research projects in the field of functional heterogeneity of cellular tumor relations in their ecosystem: the "HTE Program".

Initiation of HTE Program